Diasome’s Liver Targeted Insulin
    Research of Type 1 Diabetes
    April 18, 2019

    Diasome’s Liver Targeted Insulin

    We spoke with Robert Geho, CEO of Diasome Pharmaceuticals, Inc. — www.diasome.com — about its nanotechnology additive that delivers insulin…
    Overnight Dosing Success in T1D Children
    Treatment of Type 1 Diabetes
    April 16, 2019

    Overnight Dosing Success in T1D Children

    We spoke with Ulrike Schierloh, MD who is with the Pediatric Clinic, Centre Hospitalier de Luxembourg, Luxembourg, GD de Luxembourg…
    Aaron Kowalski Appointed New JDRF President/CEO
    Research of Type 1 Diabetes
    April 9, 2019

    Aaron Kowalski Appointed New JDRF President/CEO

    Today, the JDRF announced the appointment of Aaron J. Kowalski, Ph.D., as the nonprofit’s President and Chief Executive Officer. A…
    How I Fulfilled My Dream of Natural Childbirth Despite My T1D
    Living with Type 1 Diabetes
    April 9, 2019

    How I Fulfilled My Dream of Natural Childbirth Despite My T1D

    I have never let diabetes dictate my life. I’ve climbed mountains, RVed across foreign countries and traveled all over the…
    Basal Insulins Explained
    Medicine/Drugs
    April 4, 2019

    Basal Insulins Explained

    Many people with diabetes have developed a love-hate relationship with insulin. This life-saving, wallet-shrinking, high-fixing, low-causing, pain-to-dose wonder molecule is…
    Oxygen Critical to Practical Islet Transplants
    Research of Type 1 Diabetes
    April 2, 2019

    Oxygen Critical to Practical Islet Transplants

    We spoke with Klearchos Papas, PhD about his oxygen generator-based islet ‘tea bag’ transplant device for which the JDRF just…

    Latest News